Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 08, 2020

SELL
$26.15 - $77.24 $4.95 Million - $14.6 Million
-189,258 Closed
0 $0
Q4 2019

Feb 06, 2020

SELL
$60.18 - $154.77 $6.37 Million - $16.4 Million
-105,768 Reduced 35.85%
189,258 $13.7 Million
Q3 2019

Nov 12, 2019

SELL
$140.29 - $189.96 $810,595 - $1.1 Million
-5,778 Reduced 1.92%
295,026 $41.4 Million
Q2 2019

Aug 12, 2019

SELL
$157.85 - $183.09 $1.91 Million - $2.21 Million
-12,079 Reduced 3.86%
300,804 $55.1 Million
Q1 2019

May 10, 2019

BUY
$89.33 - $163.65 $5.91 Million - $10.8 Million
66,138 Added 26.8%
312,883 $49.8 Million
Q4 2018

Feb 12, 2019

SELL
$81.94 - $139.71 $1.38 Million - $2.35 Million
-16,790 Reduced 6.37%
246,745 $23.6 Million
Q3 2018

Nov 13, 2018

SELL
$138.11 - $169.04 $1.43 Million - $1.76 Million
-10,383 Reduced 3.79%
263,535 $37.2 Million
Q2 2018

Aug 02, 2018

BUY
$140.36 - $175.76 $34.1 Million - $42.7 Million
243,118 Added 789.34%
273,918 $42.9 Million
Q1 2018

May 11, 2018

SELL
$152.15 - $192.33 $604,948 - $764,704
-3,976 Reduced 11.43%
30,800 $4.96 Million
Q4 2017

Feb 09, 2018

SELL
$60.72 - $167.34 $417,328 - $1.15 Million
-6,873 Reduced 16.5%
34,776 $5.73 Million
Q3 2017

Nov 13, 2017

BUY
$61.4 - $88.52 $2.56 Million - $3.69 Million
41,649
41,649 $2.59 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $323M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Fiera Capital Corp Portfolio

Follow Fiera Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.